The Feasibility of Percutaneous Dilatational Tracheostomy in Immunosuppressed ICU Patients with or without Thrombocytopenia.
Marianne AngelbergerMichaela BarnikelAlessia FraccaroliJohanna TischerSofia AntonAlexandra PawlikowskiMark Op den WinkelHans Joachim StemmlerStephanie-Susanne StecherPublished in: Critical care research and practice (2022)
PDT is a feasible and safe procedure in a predominantly immunosuppressed and thrombocytopenic patient cohort without an increased risk for stoma site infections or bleeding complications.